By utilizing peptide-primarily based methods to inhibit anti-apoptotic proteins like BCL-two, programmed cell death could be induced in cancer cells, in the long run bringing about their demise. These specific methodologies show encouraging ends in augmenting the effectiveness of cancer therapy and improving affected person outcomes. An increase